• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公众对实施个性化医疗的促进因素和障碍的认知:一项系统综述

The public perception of the facilitators and barriers to implementing personalized medicine: a systematic review.

作者信息

Holden Ciara, Bignell Lauren, Mukhopadhyay Somnath, Jones Christina

机构信息

Academic Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton & Sussex Medical School, Brighton, BN2 5BE, UK.

Academic Department of General Practice, Queen Mary University of London, Mile End Rd, London, E1 4NS, UK.

出版信息

Per Med. 2019 Sep;16(5):409-420. doi: 10.2217/pme-2018-0151. Epub 2019 Oct 8.

DOI:10.2217/pme-2018-0151
PMID:31591926
Abstract

The integration of personalized medicine (PM) into mainstream healthcare will only be successful if the public understands and supports this change. The aim was to understand the public perception of the barriers and facilitators towards the use of PM. A systematic review of the literature was conducted within six databases from 2006 to 2018. Twenty-one studies with 9507 participants were included. The key themes were familiarity and willingness to use PM, perceived benefits and perceived risks of PM. The review shows that the public is generally enthusiastic about the introduction of PM, although this should be interpreted with cautious optimism due to participants having a limited familiarity of the underlying principles of PM. The study defines areas where progress can be made to enhance this understanding and addresses legitimate concerns.

摘要

只有当公众理解并支持这一变革时,将个性化医疗(PM)融入主流医疗保健才会成功。目的是了解公众对使用PM的障碍和促进因素的看法。在2006年至2018年期间,对六个数据库进行了文献系统综述。纳入了21项研究,共9507名参与者。关键主题包括对PM的熟悉程度和使用意愿、PM的感知益处和感知风险。综述表明,公众总体上对引入PM持热情态度,不过鉴于参与者对PM基本原则的熟悉程度有限,对此应持谨慎乐观的态度。该研究确定了可以取得进展以增进这种理解的领域,并解决了合理关切的问题。

相似文献

1
The public perception of the facilitators and barriers to implementing personalized medicine: a systematic review.公众对实施个性化医疗的促进因素和障碍的认知:一项系统综述
Per Med. 2019 Sep;16(5):409-420. doi: 10.2217/pme-2018-0151. Epub 2019 Oct 8.
2
Patient and public understanding of the concept of 'personalised medicine' in relation to cancer treatment: a systematic review.患者及公众对癌症治疗中“个性化医疗”概念的理解:一项系统综述
Future Healthc J. 2021 Nov;8(3):e703-e708. doi: 10.7861/fhj.2021-0063.
3
Personalised Medicine-Implementation to the Healthcare System in Europe (Focus Group Discussions).个性化医疗——在欧洲医疗体系中的实施(焦点小组讨论)
J Pers Med. 2023 Feb 21;13(3):380. doi: 10.3390/jpm13030380.
4
THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.医学的未来,通过精准医学实现医疗保健创新:卡塔尔的政策案例研究。
Life Sci Soc Policy. 2020 Nov 1;16(1):12. doi: 10.1186/s40504-020-00107-1.
5
What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.药学和医学专业的学生对药物基因组学和个性化医学教育有何看法?马来西亚健康科学领域的认知、态度和观念
OMICS. 2021 Jan;25(1):52-59. doi: 10.1089/omi.2020.0178. Epub 2020 Nov 10.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?个性化医疗与靶向治疗的定义:医学熟悉度重要吗?
J Pers Med. 2021 Jan 4;11(1):26. doi: 10.3390/jpm11010026.
8
Representing a "revolution": how the popular press has portrayed personalized medicine.代表“革命”:大众媒体如何描述个性化医学。
Genet Med. 2018 Sep;20(9):950-956. doi: 10.1038/gim.2017.217. Epub 2018 Jan 4.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Barriers and Facilitators to the Implementation of Personalised Medicine across Europe.欧洲个性化医疗实施的障碍与促进因素
J Pers Med. 2023 Jan 23;13(2):203. doi: 10.3390/jpm13020203.

引用本文的文献

1
Patient, parent and professional expert perspectives on personalized regenerative implants: a qualitative focus group study.患者、家长和专业专家对个性化再生植入物的看法:一项定性焦点小组研究。
Regen Med. 2024;19(7-8):393-406. doi: 10.1080/17460751.2024.2386214. Epub 2024 Sep 2.
2
Public engagement with genomics.公众对基因组学的参与。
Wellcome Open Res. 2023 Sep 18;8:310. doi: 10.12688/wellcomeopenres.19473.2. eCollection 2023.
3
Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation.
公共价值观和指导原则在肾移植分配标准中实施表位相容性:来自加拿大在线公众讨论的结果。
BMC Public Health. 2023 May 10;23(1):844. doi: 10.1186/s12889-023-15790-w.
4
Barriers and Facilitators to the Implementation of Personalised Medicine across Europe.欧洲个性化医疗实施的障碍与促进因素
J Pers Med. 2023 Jan 23;13(2):203. doi: 10.3390/jpm13020203.
5
Readiness to Accept Genetic Testing for Personalized Medicine: Survey Findings on the Role of Socio-Demographic Characteristics, Health Vulnerabilities, Perceived Genetic Risk and Personality Factors.接受个性化医疗基因检测的意愿:关于社会人口特征、健康脆弱性、感知遗传风险和人格因素作用的调查结果
J Pers Med. 2022 Nov 3;12(11):1836. doi: 10.3390/jpm12111836.
6
Real-World Implementation of Precision Psychiatry: A Systematic Review of Barriers and Facilitators.精准精神病学的现实世界实施:障碍与促进因素的系统评价
Brain Sci. 2022 Jul 16;12(7):934. doi: 10.3390/brainsci12070934.
7
Patient and public understanding of the concept of 'personalised medicine' in relation to cancer treatment: a systematic review.患者及公众对癌症治疗中“个性化医疗”概念的理解:一项系统综述
Future Healthc J. 2021 Nov;8(3):e703-e708. doi: 10.7861/fhj.2021-0063.
8
Religious Perspectives on Precision Medicine in Singapore.新加坡精准医学的宗教视角。
Asian Bioeth Rev. 2021 Sep 6;13(4):473-483. doi: 10.1007/s41649-021-00180-4. eCollection 2021 Dec.
9
Rural Community Perceptions and Interests in Pharmacogenomics.农村社区对药物基因组学的认知与兴趣
Healthcare (Basel). 2020 Jun 5;8(2):159. doi: 10.3390/healthcare8020159.